탭메뉴
| 번호 | 구분 | 제목 |
|---|---|---|
| 23 | (국외)SCI | Drug?Drug Interactions between Tamsulosin and Mirabegron in Healthy Individuals Do Not Affect Pharmacokinetics and Hemodynamic Parameters Significantly |
| 22 | (국외)SCI | A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State |
| 21 | (국외)SCI | Pharmacokinetics and Food EffectBetween a 100-mg Sustained-ReleaseTablet and a 50-mg Immediate-ReleaseTablet of Vildagliptin in HealthySubjects |
| 20 | (국외)기타 | Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation |
| 19 | (국외)SCI | Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration |
| 18 | (국외)SCI | The Safety of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World Data |
| 17 | (국외)SCIE | Tissue pharmacokinetics of DHP107, a novel lipid-based oral formulation of paclitaxel, in mice and patients by positron emission tomography |
| 16 | (국외)SCIE | Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia |
| 15 | (국내)SCOPUS | Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects |
| 14 | (국외)SCIE | Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor-Mediated Recycling of HL2351, a Novel Hybrid Fc-Fused Interleukin-1 Receptor Antagonist, to Optimize Dosage Regimen |
1
Copyright ⓒ chamc, All rights reserved.
